JAZZ PHARMACEUTICAL (J7Z BE) stock market data APIs
€157.823
0.05(0%)
as of March 11, 2026
Try our APIs with
free plan!
JAZZ PHARMACEUTICAL Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for J7Z.BE.
Prev. Close
157.823
Open
157.927
High
158.0215
Low
157.632
52 wk Range
86.72-161.8
Market Cap
6 680 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get JAZZ PHARMACEUTICAL data using free add-ons & libraries
Get JAZZ PHARMACEUTICAL Fundamental Data
JAZZ PHARMACEUTICAL Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-24
- EPS/Forecast: 6.51
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
JAZZ PHARMACEUTICAL News
New
Is Jazz Pharmaceuticals (JAZZ) One of the Best Cheap Biotech Stocks to Buy Now?
Jazz Pharmaceuticals (NASDAQ:JAZZ) is one of the best cheap biotech stocks to buy now. Jazz Pharmaceuticals (NASDAQ:JAZZ) was initiated with an Overweight rating by Barclays on February 27, with the f...
Jazz Pharmaceuticals’ Record Revenue And Cancer Data Raise Durability Question
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Jazz Pharmaceuticals (NasdaqGS:JAZZ) reported record annual revenue in its latest re...
A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Record Quarter And 2026 Guidance
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Jazz Pharmaceuticals (JAZZ) is back in the spotlight after reporting its strongest q...
Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why
What Happened? Shares of biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) jumped 13.5% in the afternoon session after the company reported better-than-expected fourth-quarter 2025 revenue and ear...
Get JAZZ PHARMACEUTICAL fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
